NEW YORK, Feb 26 – Pharmacopeia of Princeton, NJ, said Monday it would combine its four life science software units into a single entity, effective June 1.

“We’ve been acquiring different software businesses all related to drug discovery and chemical development, so we’re going to continue doing what we do, which is design and sell software to help our customers discover drugs and develop chemicals, but now we’ll just do it under one name since all the products are basically related,” Sue Rodney, manager of investor relations at Pharmacopeia, told GenomeWeb.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.